Prowormer Flavoured Tablets for Medium and Small Dogs
국가: 영국
언어: 영어
출처: HMA (Heads of Medicines Agencies)
제품 특성 요약
(SPC)
06-08-2012
이 제품에 대한 일부 문서는 현재 사용할 수 없습니다. 고객 서비스에 요청을 보내면 가능한 빨리 알려 드리겠습니다.
요청을 보내십시오.
요청을 보내십시오.
유효 성분:
febantel 150 mg, praziquantel 50 mg, pyrantel 50 mg
제공처:
CEVA Animal Health
ATC 코드:
QP52AA51
약제 형태:
Tablet
치료 그룹:
praziquantel, combinations
치료 영역:
Dogs
승인 날짜:
2011-11-23
제품 특성 요약
Revised: December 2011
AN: 00111/2011
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
PROWORMER Flavoured tablets for medium and small dogs [UK, IE]
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One tablet contains:
ACTIVE SUBSTANCES:
Febantel ............................................................................................. 150 mg
Pyrantel (as embonate) ...................................................................... 50 mg
Praziquantel ........................................................................................ 50 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
Yellow brown, oval tablet with a score line on both sides.
The tablets can be divided into equal halves.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs (adults and puppies).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of mixed infections by adult cestodes and nematodes of the following
species:
Nematodes:
Ascarids:
_Toxocara canis_, _Toxascaris leonina_ (adult and late immature forms).
Hookworms: _Uncinaria stenocephala_, _Ancylostoma caninum_ (adults).
Whipworms: _Trichuris vulpis_ (adults).
Cestodes:
Tapeworms: _Echinococcus spp., Taenia _spp., _Dipylidium caninum_ (adult and
immature forms).
4.3
CONTRAINDICATIONS
Revised: December 2011
AN: 00111/2011
Page 2 of 7
Do not use in animals with a known sensitivity to the active ingredients or to any of the
excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
As a precautionary measure to prevent the establishment of _Echinococcus _
_multilocularis_, it is recommended that all
전체 문서 읽기
